•  
  •  
  •  
  •  

2025-12-23 13:45:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE185C01017

Stock Report

  • Shree Ajit Pulp and Paper Ltd shuts down plant temporarily
  • Shree Ajit Pulp And Paper Ltd fixes Jan 18, 2024 as record date for rights issue
  • Shree Ajit Pulp and Paper Ltd resumes production process at Unit I
  • Shree Ajit Pulp and Paper Limited commences commercial production at Unit 2
  • Shree Ajit Pulp and Paper Limited to increase rights issue size to Rs. 35 crores
  • Shree Ajit Pulp and Paper Ltd to shut down plant for maintenance
  • Shree Ajit Pulp and Paper Ltd enters into MoU with Gujarat Government
  • Shree Ajit Pulp and Paper Ltd to shut down plant for 15 days
  • Shree Ajit Pulp and Paper Ltd to raise Rs. 20 crores through rights issue
  • Shree Ajit Pulp and Paper Limited to consider rights issue on Oct 28, 2022
  • ICRA reaffirms rating of Shree Ajit Pulp and Paper Ltd
  • Shree Ajit Pulp and Paper Ltd recommends dividend of Rs. 1
  • Shree Ajit Pulp And Paper Ltd achieves highest ever production in Jan 2022
  • Shree Ajit Pulp and Paper Ltd achieves highest ever production in December 2021
  • Shree Ajit Pulp and Paper Ltd achieves highest ever production in October 2021

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024